Vontobel Holding’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $32M | Sell |
71,798
-3,008
| -4% | -$1.34M | 0.1% | 141 |
|
|
2025
Q1 | $36.3M | Sell |
74,806
-114,143
| -60% | -$55.3M | 0.13% | 119 |
|
|
2024
Q4 | $76.1M | Buy |
188,949
+75,653
| +67% | +$30.5M | 0.26% | 64 |
|
|
2024
Q3 | $52.7M | Sell |
113,296
-45,534
| -29% | -$21.2M | 0.17% | 102 |
|
|
2024
Q2 | $74.4M | Buy |
158,830
+50,450
| +47% | +$23.6M | 0.24% | 65 |
|
|
2024
Q1 | $45.3M | Buy |
108,380
+46,946
| +76% | +$19.6M | 0.36% | 72 |
|
|
2023
Q4 | $25M | Sell |
61,434
-6,200
| -9% | -$2.52M | 0.21% | 121 |
|
|
2023
Q3 | $23.5M | Sell |
67,634
-363
| -0.5% | -$126K | 0.22% | 119 |
|
|
2023
Q2 | $23.9M | Buy |
67,997
+10,387
| +18% | +$3.66M | 0.21% | 122 |
|
|
2023
Q1 | $18.2M | Sell |
57,610
-5,089
| -8% | -$1.6M | 0.17% | 142 |
|
|
2022
Q4 | $17.9M | Buy |
62,699
+3,573
| +6% | +$1.02M | 0.18% | 137 |
|
|
2022
Q3 | $17.3M | Sell |
59,126
-13,662
| -19% | -$4M | 0.2% | 118 |
|
|
2022
Q2 | $20.4M | Sell |
72,788
-17,903
| -20% | -$5.02M | 0.22% | 112 |
|
|
2022
Q1 | $23.3M | Sell |
90,691
-26,006
| -22% | -$6.67M | 0.2% | 111 |
|
|
2021
Q4 | $26M | Buy |
116,697
+18,953
| +19% | +$4.22M | 0.22% | 106 |
|
|
2021
Q3 | $17.7M | Buy |
97,744
+19,318
| +25% | +$3.5M | 0.16% | 129 |
|
|
2021
Q2 | $15.4M | Buy |
78,426
+11,786
| +18% | +$2.32M | 0.13% | 137 |
|
|
2021
Q1 | $14.3M | Buy |
66,640
+8,572
| +15% | +$1.84M | 0.11% | 131 |
|
|
2020
Q4 | $12.4M | Buy |
+58,068
| New | +$12.4M | 0.08% | 142 |
|